Sarepta Therapeutics Inc. (SRPT)
Market Closed
4 Jun, 20:00
$
16. 66
+0.42
+2.5862%
After Hours
$
+0.13 +0.7803% 16. 79
1.76B Market Cap
- P/E Ratio
- Div Yield
2.07M Volume
-6.99 Eps
$ 16.24
Previous Close 
Want to track SRPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics Inc. (SRPT) Statistics
Valuation metrics
Market Cap 1.76B
Enterprise value 2.23B
Trailing P/E (ttm) 19.98
Forward P/E 6.76
PEG ratio -0.06
Price/Sales (ttm) 0.97
Price/Book (mrq) 1.87
Enterprise Value/Revenue 1.01
Enterprise Value/EBITDA -3.64
Overview
Shares outstanding 104.96M
Float 91.78M
Shares short 25.33M
% Held by insiders 0.05%
% Held by institutions 0.9%
Average volume (10 days) 2.69M
Average volume (90 days) 3.19M
Price summary
52-Week low 10.42
52-Week high 43.92
Beta 0.28
50-Day moving average 19.24
200-Day moving average 19.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 12 Jul 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.32%
Operating margin -0.93%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.53%
Income Statement
Revenue (ttm) 2.2B
Revenue per share (ttm) 21.96
Quarterly revenue growth (yoy) -0.33%
Gross profit (ttm) -163.43M
EBITDA -613.25M
Net income to common (ttm) -713.41M
Diluted EPS (ttm) -7.13
Quarterly earnings growth (yoy) -0.33%
Balance Sheet
Total cash (mrq) 939.65M
Total cash per share (mrq) 8.95
Total debt (mrq) 1.04B
Total Debt/Equity (mrq) 91.14
Current ratio (mrq) 2.32%
Book value per share (mrq) 10.87
Cash Flow
Cash flow statement -205.48M
Levered free cash flow (LFCF) 95.92M
